Lilly accuses the sellers of offering illicit versions of its experimental weight loss drug, as CEO Dave Ricks pushes regulators to step up enforcement.
Recap by typeshit. Full story at The Washington Post.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
After advisers backed adding BPC-157, TB-500, KPV and others to the 503A bulks list, pharmacists are waiting on the FDA's final decision.
South Africa's medicines regulator now spells out how synthetic peptide medicines can be legally registered and sold, a first for the country.
Officers say the seized pharmaceuticals were worth $280,106.20 in total, part of a wider push against smuggled weight loss and peptide products.
JAMA Medical News flags unapproved GLP-1 drugs sold cheaply online, pointing to missing regulation, unknown contents and safety risks.
JAMA flags unapproved GLP-1 drugs sold without regulation, pointing to unknown contents and safety concerns for buyers chasing cheaper shots.
Loading…